Current allegations in the GLP-1 litigation commonly involve claims that: manufacturers failed to provide adequate warnings about delayed gastric emptying and severe gastrointestinal injury risks GLP-1 drugs may cause gastroparesis, ileus, or intestinal obstruction in certain patients patients were not properly informed of the potential side effects beyond common nausea and appetite suppression warning labels did not clearly reflect the risk of long-term digestive dysfunction some patients experienced permanent or prolonged impairment after discontinuing the medication the drugs were marketed in ways that downplayed serious adverse outcomes These allegations are not limited to Victoza, but Victoza has become part of this broader litigation because its mechanism of action overlaps with other GLP-1 medications now facing coordinated claims
Wrap two ounces of deli turkey around a stick of string cheese
Smaller portions can mean missed nutrients, while planning what to eat on GLP-1s every day can feel like hard work when youre not especially hungry
Regular physical activity is another key component
Lyophilized BPC 157 typically appears as white or off-white powder
Signs of severe dehydration: Dizziness when standing, rapid heartbeat, very dark urine, confusion, or no urination for 8+ hours